Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients
Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients
批准号:
10687823
负责人:
Pamela B Davis
金额:
$36.23万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-22 至 2024-08-31
关键词:
18 year old2019-nCoVAdultAffectAgeAlcohol consumptionAlcoholsAmericanAnxietyAreaBehavioralBereavementBiologicalCOVID-19COVID-19 pandemic effectsCOVID-19 patientCOVID-19 riskCOVID-19 survivorsCOVID-19 susceptibilityCannabisCategoriesCenters for Disease Control and Prevention (U.S.)Central Nervous SystemCessation of lifeCocaineCognitiveComplexConsumptionCrowdingDatabasesDiagnosisDiseaseEconomic BurdenElectronic Health RecordEvolutionFamilyFeeling suicidalFrequenciesFrightGeneral PopulationGrief reactionHeart DiseasesHeavy DrinkingHospitalizationHumanImpairmentIncomeInfectionInterventionInvestigationMalignant NeoplasmsMeasuresMedicalMental DepressionMental HealthMental disordersNeurologicOpioidOrganismOutcomePatientsPost-Traumatic Stress DisordersPrevalencePsyche structurePsychosesPublic HealthRiskSARS-CoV-2 infectionSalesSchizophreniaSiteSocial isolationStimulantSubstance Use DisorderSurvivorsTestingTimeTobaccoUpdateVariantVirusVirus DiseasesWorkplacealcohol riskalcohol use disorderchronic liver diseasecomorbiditycoronavirus diseasecostelectronic health databasegender disparityhigh riskpandemic diseasepreventracial disparityresponsesocialsocial contactsynergismtherapy designvaccine hesitancyviral transmission
中文摘要
项目概要
疫情期间,由于社会孤立和悲伤,酒精消费量不断增加。 SARS-CoV-2
本身对中枢神经系统有重大影响。当两个如此重要的公共卫生威胁
交叉,了解它们的相互作用和潜在的协同作用至关重要。在这个名为“表征
基于实时分析的 COVID-19 和酒精使用障碍之间的多方面相互作用
6200 万成年患者的电子健康记录”,我们建议:1)描述对
酒精使用障碍 (AUD) 患者中的 COVID-19(“AUD → COVID-19”),考虑种族和性别
差异,并跟踪其随时间的演变; 2) 描述 COVID-19 感染和社会流行病的特征
背景影响 AUD 的风险(“COVID-19 加上大流行背景 → AUD”),考虑种族和性别
差异,并随着时间的推移跟踪这些变化; 3) 描述主要精神疾病的患病率,
AUD 和 COVID-19 患者中的其他物质使用障碍和严重后果
(“AUD COVID-19→结果”)并随着时间的推移跟踪这些结果。我们的研究将确定潜在的
及时干预以保护患者或减轻 COVID-19 大流行和 AUD 最严重影响的领域,
单独和组合。如果病毒变种再次激增,或者如果
患有 AUD 的人对疫苗的犹豫程度更大。如果我们再次发生大流行,它也将为此类研究提供信息
与另一种生物体相比,我们在这些研究中采用的方法是使用全国范围的数据库
电子健康记录可能为快速、实时分析和结果铺平道路,以告知我们的控制
措施。
英文摘要
PROJECT SUMMARY
During the pandemic, with social isolation and grief as drivers, alcohol consumption is increasing. SARS-CoV-2
itself has substantial impact on the central nervous system. When two such important public health menaces
intersect, it is crucial to understand their interaction and potential synergy. In this project titled “Characterize
multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of
electronic health records of 62 million adult patients”, we propose to: 1) characterize susceptibility to
COVID-19 in patients with alcohol use disorder (AUD) (“AUD → COVID-19”), consider racial and gender
disparity, and follow its evolution over time; 2) characterize how COVID-19 infection and the social pandemic
context impact the risk of AUD (“COVID-19 plus pandemic context → AUD”), consider racial and gender
disparity, and follow these changes over time; and 3) characterize prevalence of major psychiatric disorders,
other substance use disorders and severe outcomes among patients with both AUD and COVID-19
(“AUD+COVID-19 → outcomes”) and to follow these outcomes over time. Our studies will identify potential
areas for timely interventions to protect patients or mitigate the worst effects of COVID-19 pandemic and AUD,
singly and combined. This is especially important if there should be another surge with a virus variant, or if
vaccine hesitancy is greater in those with AUD. It will also inform such studies if we have another pandemic
with another organism, for the approaches we pioneer in these studies using nation-wide database of
electronic health records may pave the way for rapid, real-time analytics and results to inform our control
measures.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments
-
批准号:10417884
-
项目类别:
-
资助金额:$234.2万
-
财政年份:2022
-
负责人:Pamela B Davis
-
依托单位:
Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients
-
批准号:10377762
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2021
-
负责人:Pamela B Davis
-
依托单位:
Characterize multifaceted interactions between COVID-19 and alcohol use disorder based on real-time analysis of electronic health records of 62 million adult patients
-
批准号:10491155
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2021
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8366088
-
项目类别:
-
资助金额:$419.91万
-
财政年份:2011
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8366086
-
项目类别:
-
资助金额:$169.96万
-
财政年份:2011
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:8366087
-
项目类别:
-
资助金额:$139.97万
-
财政年份:2011
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8366090
-
项目类别:
-
资助金额:$169.96万
-
财政年份:2011
-
负责人:Pamela B Davis
-
依托单位:
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA
-
批准号:8366089
-
项目类别:
-
资助金额:$233.28万
-
财政年份:2011
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8173797
-
项目类别:
-
资助金额:$428.07万
-
财政年份:2010
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8173795
-
项目类别:
-
资助金额:$160.53万
-
财政年份:2010
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:8173796
-
项目类别:
-
资助金额:$214.03万
-
财政年份:2010
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8173799
-
项目类别:
-
资助金额:$160.53万
-
财政年份:2010
-
负责人:Pamela B Davis
-
依托单位:
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA
-
批准号:8173798
-
项目类别:
-
资助金额:$107.02万
-
财政年份:2010
-
负责人:Pamela B Davis
-
依托单位:
Case Western Researve Clinical and Translational Science Institute (UL1)
-
批准号:7901706
-
项目类别:
-
资助金额:$97.88万
-
财政年份:2009
-
负责人:Pamela B Davis
-
依托单位:
Nucleolin-mediated cell entry of DNA nanoparticles
-
批准号:7849651
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2009
-
负责人:Pamela B Davis
-
依托单位:
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA (UL1): BPCA
-
批准号:7961847
-
项目类别:
-
资助金额:$47.8万
-
财政年份:2009
-
负责人:Pamela B Davis
-
依托单位:
Nucleolin-mediated cell entry of DNA nanoparticles
-
批准号:7701310
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2009
-
负责人:Pamela B Davis
-
依托单位:
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA (UL1): BPCA
-
批准号:7961848
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2009
-
负责人:Pamela B Davis
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:7719785
-
项目类别:
-
资助金额:$210.03万
-
财政年份:2008
-
负责人:Pamela B Davis
-
依托单位:
CASE WESTERN RESERVE UNIVERSITY/CLEVELAND CLINIC CTSA
-
批准号:7719787
-
项目类别:
-
资助金额:$420.04万
-
财政年份:2008
-
负责人:Pamela B Davis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
微米和纳米塑料作用下2019-nCoV抗病毒药物利巴韦林对河蚬的毒性作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:郭晓宇
-
依托单位:
2019-nCoV感染导致人体淋巴细胞减低机制及其对机体免疫功能影响
-
批准号:82030002
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:曹彬
-
依托单位:
基于人口流动大数据的新型冠状病毒(2019-nCoV)输出感染风险及接触网络传播模型研究
-
批准号:--
-
项目类别:--
-
资助金额:135万元
-
批准年份:2020
-
负责人:吕欣
-
依托单位:
云南驯养野生动物中新型冠状病毒(2019-nCoV)溯源调查与验证
-
批准号:--
-
项目类别:--
-
资助金额:140万元
-
批准年份:2020
-
负责人:夏雪山
-
依托单位:
新型冠状病毒(2019-nCoV)反向遗传系统及啮齿类感染模型的建立与应用
-
批准号:--
-
项目类别:--
-
资助金额:150万元
-
批准年份:2020
-
负责人:黄耀伟
-
依托单位:
血必净预防2019-nCoV肺炎发生ARDS及机制研究
-
批准号:82041003
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:宋元林
-
依托单位:
新型冠状病毒2019-nCoV复制复合体关键蛋白的功能与潜在药物靶点研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:郭德银
-
依托单位:
2019-nCoV蝙蝠及人群代表性流行株致病能力的比较研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:周鹏
-
依托单位:
人新型冠状病毒2019-nCoV受体利用介导的种间传播和感染机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:140万元
-
批准年份:2020
-
负责人:葛行义
-
依托单位:
2019-nCoV“不典型症状”感染者的宿主因素及其作用机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:张文宏
-
依托单位: